title: Response to: Dopamine dysregulation syndrome and psychosis in 24-h intestinal levodopa infusion for Parkinson's disease.
authors.affiliation: St George's University of London, London, UK.
authors.forename: Lucia
authors.initials: L
authors.lastname: Ricciardi
authors.affiliation: Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Fasano
authors.affiliation: Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA. Electronic address: alberto.espay@uc.edu.
authors.forename: Alberto J
authors.initials: AJ
authors.lastname: Espay
mesh_terms: D000978:Antiparkinson Agents; D004298:Dopamine; D006801:Humans; D007980:Levodopa; D010300:Parkinson Disease; D011618:Psychotic Disorders
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa; D004298:Dopamine
keywords: Capgras syndrome; Impulse control disorders; Intrajejunal levodopa; Non-motor symptoms; Parkinson’s disease; Psychosis